Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

B. E. Sands, S. Bank, C. A. Sninsky, M. Robinson, S. Katz, J. W. Singleton, Jr Miner, M. A. Safdi, S. Galandiuk, S. B. Hanauer, G. W. Varilek, A. L. Buchman, V. D. Rodgers, B. Salzberg, B. Cai, J. Loewy, M. F. Debruin, H. Rogge, M. Shapiro, U. S. Schwertschlag

Research output: Contribution to journalArticlepeer-review

207 Scopus citations

Fingerprint

Dive into the research topics of 'Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science